imperial-hastanesi

Uzm. Dr. Ali Caner ÖZDÖVER

Medical Oncology Specialist

Online Appointment

Uzm. Dr. Ali Caner ÖZDÖVER

Medical Oncology Specialist

Curriculum Vitae

I graduated from Hacettepe University Faculty of Medicine in 2010. I completed my internal medicine residency at Gaziantep University Internal Medicine Clinic. Following a one-year hematology fellowship at Trakya University Department of Hematology, I completed my medical oncology subspecialty training at KTU Department of Medical Oncology in 2022. After working at Trabzon Kaşüstü Kanuni Training and Research Hospital for four years, I started my new position at Private Imperial Hospital in 2026.

Education

  • UNDERGRADUATE :FACULTY OF MEDICINE - HACETTEPE UNIVERSITY FACULTY OF MEDICINE 2010
  • SPECIALIZATION :INTERNAL MEDICINE - GAZİANTEP UNIVERSITY FACULTY OF MEDICINE 2017
  • SUBSPECIALTY :MEDICAL ONCOLOGY - TRABZON KTÜ FACULTY OF MEDICINE 2022
  • Professional Career

  • HAKKARİ STATE HOSPITAL 2010-2012
  • GAZİANTEP UNIVERSITY INTERNAL MEDICINE CLINIC 2012-2017
  • TRAKYA UNIVERSITY INTERNAL MEDICINE HEMATOLOGY CLINIC 2017-2018
  • KTÜ INTERNAL MEDICINE MEDICAL ONCOLOGY CLINIC 2018-2022

Foreign Language

  • English
  • Medical Interests
  • Lung Cancer
  • Colon (Large Intestine) Cancer
  • Breast Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Bile Duct Cancer
  • Brain Tumors

Academic Research 1- “Evaluation of Cardiac Parameters in Bone Marrow Transplant Patients: Effect of Pulmonary Artery Pressure on Survival” Turk J Haematol. 2019 Feb 7;36(1):19-24. doi: 10.4274/ tjh.galenos. 2018.2018.0015. Epub 2018 Oct 24. 2- “Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life” Turk J Haematol. 2019 Feb 7;36(1):43-47. doi: 10.4274/tjh.galenos.2018.2018.0190. Epub 2018 Jun 8. 3- “A case of refractory chronic lymphocytic leukaemia with an unusual course” Natl Med J India. 2019 Nov-Dec;32(6):347-349. doi: 10.4103/0970-258X.303614. 4- “Factors Affecting the Efficacy of Regorafenib in Metastatic Colorectal Cancer: Is Tumour Sidedness Important?” J Coll Physicians Surg Pak. 2023 Jun;33(6):659-665. doi: 10.29271/ jcpsp.2023.06.659. 5- Single Center Experience of Sunitinib Vs Pazopanib in Renal Cell Carcinoma Treatment 2021 TTOD Congress 6- Rare Breast Metastasis Case Presentation in Colon Cancer TTOD 2020 Congress

Mid-Week: Hafta İçi: 08:00 - 17:00
Saturday: Cumartesi: 08:00 - 13:00
Update Date : 29.07.2026
Call WhatsApp